A detailed history of Spectrum Wealth Counsel, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Spectrum Wealth Counsel, LLC holds 247 shares of VRTX stock, worth $111,389. This represents 0.01% of its overall portfolio holdings.

Number of Shares
247
Previous 320 22.81%
Holding current value
$111,389
Previous $150 Million 23.41%
% of portfolio
0.01%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$460.0 - $505.78 $33,580 - $36,921
-73 Reduced 22.81%
247 $115 Million
Q2 2024

Aug 08, 2024

SELL
$392.81 - $485.53 $2.31 Million - $2.86 Million
-5,881 Reduced 94.84%
320 $150 Million
Q1 2024

May 06, 2024

SELL
$407.69 - $446.08 $17,122 - $18,735
-42 Reduced 0.67%
6,201 $2.59 Billion
Q4 2023

Feb 14, 2024

BUY
$343.0 - $410.68 $2.14 Million - $2.56 Million
6,243 New
6,243 $2.54 Billion

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Spectrum Wealth Counsel, LLC Portfolio

Follow Spectrum Wealth Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spectrum Wealth Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spectrum Wealth Counsel, LLC with notifications on news.